This approval represents a significant regulatory milestone, making Proliv™Rx the first and only at-home neuromodulation ...

A new breakthrough study from the Rotman Research Institute at Baycrest, University of Toronto (Motsenyat et al., Brain Stimulation 2025) shows that brief sessions of pulsed photobiomodulation (PBM) ...

One intriguing method that could be used to form the qubits needed for quantum computers involves electrons hovering above ...

Ractigen Therapeutics is pleased to announce that the first patient has been dosed in the Phase II clinical trial of RAG-17, an innovative siRNA therapy targeting SOD1-mutated amyotrophic lateral ...

D organoids, derived from stem cells or patient tissues, faithfully replicate the architecture and functions specific to various organs with remarkable ...

Bright Minds Biosciences (DRUG) stays a Strong Buy after Phase 2 BMB-101 seizure-reduction data; see 2026 catalysts, ...

Amazon's Project Kuiper secures regulatory approval in Nigeria, introducing competition to Starlink and enhancing broadband ...

Nigeria’s satellite broadband market is entering a new competitive phase after NCC granted Amazon’s Project Kuiper a 7-year ...

Central to the exhibit will be a live demonstration of the Optikos LensCheckTM featuring Cobot Loading and OpTest® ...

We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...

Morse Micro is making available the HaLowLink 2, the latest version of its long‑range Wi‑Fi HaLow networking platform.